Long-term use of an ultrapotent topical steroid for the treatment of vulval lichen sclerosus is safe

J Obstet Gynaecol. 2016;36(2):276-7. doi: 10.3109/01443615.2015.1049252. Epub 2015 Oct 22.
No abstract available

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / adverse effects
  • Candidiasis, Vulvovaginal / chemically induced
  • Clobetasol / administration & dosage*
  • Clobetasol / adverse effects
  • Diflucortolone / administration & dosage
  • Diflucortolone / adverse effects
  • Diflucortolone / analogs & derivatives*
  • Female
  • Herpes Genitalis / chemically induced
  • Humans
  • Middle Aged
  • Papillomavirus Infections / chemically induced
  • Telangiectasis / chemically induced
  • Time Factors
  • Vulvar Lichen Sclerosus / drug therapy*
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • diflucortolone valerate
  • Clobetasol
  • Diflucortolone